<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 26 Mar 2021 19:19:42 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>肿瘤治疗新秀：mRNA疫苗</title><link>https://mp.weixin.qq.com/s/3lyfNWIpRLrmoWcLc5SaqA</link><description></description><content:encoded><![CDATA[肿瘤治疗新秀：mRNA疫苗]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:53:43 +0800</pubDate></item><item><title>抗体药物动态-20210326</title><link>https://mp.weixin.qq.com/s/ckcZ5SDsyX8NJVK40WczuA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210326]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:53:43 +0800</pubDate></item><item><title>免疫损伤后的T细胞再生</title><link>https://mp.weixin.qq.com/s/b3jHx6P7lAvYqmhlQn0GpA</link><description></description><content:encoded><![CDATA[免疫损伤后的T细胞再生]]></content:encoded><pubDate>Thu, 25 Mar 2021 18:57:34 +0800</pubDate></item><item><title>【盘点】ADC药物的江湖</title><link>https://mp.weixin.qq.com/s/u845xbyvqYiNAQsv0h6eqg</link><description></description><content:encoded><![CDATA[【盘点】ADC药物的江湖]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:26:09 +0800</pubDate></item><item><title>抗体药物动态-20210324</title><link>https://mp.weixin.qq.com/s/SvGsbvXCjcLQedAWg2wIyA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210324]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:26:09 +0800</pubDate></item><item><title>VEGF-VEFGR通路</title><link>https://mp.weixin.qq.com/s/TXo8t3sKqZlXUZ2ollWX7w</link><description></description><content:encoded><![CDATA[VEGF-VEFGR通路]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:16:21 +0800</pubDate></item><item><title>Science重磅：CAR-T攻克实体瘤的质的飞跃，只杀癌细胞，不伤健康细胞</title><link>https://mp.weixin.qq.com/s/47X_6Ci7WQiGVrvUfQHWow</link><description></description><content:encoded><![CDATA[Science重磅：CAR-T攻克实体瘤的质的飞跃，只杀癌细胞，不伤健康细胞]]></content:encoded><pubDate>Mon, 22 Mar 2021 19:07:04 +0800</pubDate></item><item><title>抗体药物动态-20210322</title><link>https://mp.weixin.qq.com/s/fabIs5ueuF7HKpQRP5N5FQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210322]]></content:encoded><pubDate>Mon, 22 Mar 2021 19:07:04 +0800</pubDate></item><item><title>CAR T细胞生产中的问题和挑战</title><link>https://mp.weixin.qq.com/s/zftUvnvnwjvn7lWfAZiTFQ</link><description></description><content:encoded><![CDATA[CAR T细胞生产中的问题和挑战]]></content:encoded><pubDate>Wed, 17 Mar 2021 19:17:02 +0800</pubDate></item><item><title>抗体药物动态-20210317</title><link>https://mp.weixin.qq.com/s/02Ko6rph92wMT1fj5hmJ9Q</link><description></description><content:encoded><![CDATA[抗体药物动态-20210317]]></content:encoded><pubDate>Wed, 17 Mar 2021 19:17:02 +0800</pubDate></item><item><title>后PD-(L)1时代：开启第二波热潮的免疫新靶点</title><link>https://mp.weixin.qq.com/s/JXM6a7TNWqlH1P9218VhFA</link><description></description><content:encoded><![CDATA[后PD-(L)1时代：开启第二波热潮的免疫新靶点]]></content:encoded><pubDate>Tue, 16 Mar 2021 19:04:53 +0800</pubDate></item><item><title>抗体药物动态-20210315</title><link>https://mp.weixin.qq.com/s/bdu5WiogpQ0Zlwd_KP4tvw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210315]]></content:encoded><pubDate>Mon, 15 Mar 2021 19:48:54 +0800</pubDate></item><item><title>抗体药物动态-20210311</title><link>https://mp.weixin.qq.com/s/Wow7ARrzj7pib1t4OlQhzg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210311]]></content:encoded><pubDate>Thu, 11 Mar 2021 18:45:37 +0800</pubDate></item><item><title>Roche等开发SAR-T：2+1双抗作为活性和安全开关</title><link>https://mp.weixin.qq.com/s/RB5C3rPDhwVt7PaoGqii2w</link><description></description><content:encoded><![CDATA[Roche等开发SAR-T：2+1双抗作为活性和安全开关]]></content:encoded><pubDate>Wed, 10 Mar 2021 18:43:55 +0800</pubDate></item><item><title>抗体药物动态-20210310</title><link>https://mp.weixin.qq.com/s/DW6Sda_21IK4wuRK0CP3KQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210310]]></content:encoded><pubDate>Wed, 10 Mar 2021 18:43:55 +0800</pubDate></item></channel></rss>